Craft

Masimo

Stock Price

$141.1

2024-10-29

Market Capitalization

$7.5 B

2024-10-29

Revenue

$2 B

FY, 2023

Masimo Summary

Company Summary

Overview
Masimo Corporation is a medical technology company that develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions. Its patient monitoring solutions generally incorporate a monitor or circuit board, single-patient use or reusable sensors, software and/or cables. Its core business is Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The product offerings also include noninvasive monitoring of blood constituents with an optical signature, optical regional oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain and addiction reduction, hospital automation, and connectivity solutions and home wellness and monitoring.
Type
Public
Status
Active
Founded
1989
HQ
Irvine, CA, US | view all locations
Website
https://www.masimo.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Joe Kiani

    Joe Kiani, Chief Executive Officer & Chairman of the Board

  • Anand Sampath

    Anand Sampath, Director, Systems Engineering

  • Micah Young

    Micah Young, Executive Vice President & Chief Financial Officer

  • Jon Coleman

    Jon Coleman, President, Worldwide OEM & Global Health

Operating MetricsView all

Types of Clients Served

6
14.3%

FY, 2022

Facility Space Leased, sq. ft.

1.2M
129.4%

FY, 2022

Certifications

1

FY, 2021

LocationsView all

24 locations detected

  • Irvine, CA HQ

    United States

    52 Discovery

  • Macquarie Park, NSW

    Australia

    Suite 5.04, Level 5 Avaya House 123 Epping Road

  • Wien, Wien

    Austria

    Mariahilfer Str. 136

  • São Paulo, SP

    Brazil

    Al. Tangará, 80 - 402 - Granja Viana

  • Vancouver, BC

    Canada

    666 Burrard St

  • Shanghai, Shanghai Shi

    China

    Unit 4905, Office Tower of Raffles City, No . 268 Xizang Road(M)

and 18 others

Masimo Financials

Summary Financials

Revenue (Q3, 2024)
$504.6M
Gross profit (Q3, 2024)
$263.2M
Net income (Q3, 2024)
$9.8M
Cash (Q3, 2024)
$158.5M
EBIT (Q3, 2024)
$30.1M
Enterprise value
$8.2B

Footer menu